KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Nektar Therapeutics (NKTR) Interest & Investment Income (2023 - 2025)

Historic Interest & Investment Income for Nektar Therapeutics (NKTR) over the last 8 years, with Q3 2025 value amounting to $2.8 million.

  • Nektar Therapeutics' Interest & Investment Income fell 1798.08% to $2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.6 million, marking a year-over-year decrease of 3444.2%. This contributed to the annual value of $14.5 million for FY2024, which is 2372.03% down from last year.
  • According to the latest figures from Q3 2025, Nektar Therapeutics' Interest & Investment Income is $2.8 million, which was down 1798.08% from $2.0 million recorded in Q2 2025.
  • In the past 5 years, Nektar Therapeutics' Interest & Investment Income registered a high of $5.2 million during Q3 2023, and its lowest value of $2.0 million during Q2 2025.
  • Moreover, its 3-year median value for Interest & Investment Income was $3.9 million (2024), whereas its average is $3.7 million.
  • Its Interest & Investment Income has fluctuated over the past 5 years, first tumbled by 265.28% in 2024, then plummeted by 4952.58% in 2025.
  • Over the past 3 years, Nektar Therapeutics' Interest & Investment Income (Quarter) stood at $4.6 million in 2023, then crashed by 36.28% to $2.9 million in 2024, then decreased by 4.18% to $2.8 million in 2025.
  • Its Interest & Investment Income stands at $2.8 million for Q3 2025, versus $2.0 million for Q2 2025 and $2.9 million for Q1 2025.